Provider Review

Brand-nameCompoundedUpdated April 2026

Hers GLP-1 Review

Name: Hers GLP-1 Program
Brand: Hers
Price: 199 USD
Availability: InStock
Rating: 7.3 (1 reviews)

Reviewed by Iacob Pastina · Independent Editor

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Independently researched. Every statistic links to a primary source (NEJM, JAMA, FDA, CMS, or the provider's official disclosures). Affiliate links do not influence scoring or recommendations. Last verified April 2026.

Visit Hers

Our Score

7.3/10

Starting Price$199/mo

Medication TypeBoth

InsuranceNot Accepted

Ranking#35 of 46

Hers scores 7.3/10 in our independent review, starting at $199/mo for brand-name and compounded GLP-1 medications. The 2026 Novo Nordisk partnership changed Hers' product materially — FDA-approved Wegovy pen and Wegovy oral pill now start at $149/mo, making Hers one of the cheapest brand-name GLP-1 routes on the market. The platform also added compounded tirzepatide ($199–$299/mo) and Zepbound access via the Lilly partnership.

Quick Facts

Monthly Cost

From $199/mo

Consultation

Included

Availability

All 50 States

Insurance

Not Accepted

Shipping

Free

Cancellation

Cancel anytime online or thr...

What We Like

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

What Could Be Better

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

✓Best For

•Women who want brand-name Wegovy at market-leading cash pricing ($149/mo), or a female-focused telehealth experience from a trusted NYSE-listed brand with integrated health services.

✗Not Ideal For

•Women who want personalized high-touch care or the absolute lowest compounded price. Men should see Hims instead.

How Hers Works

Download the Hers App & Complete Intake

Download the Hers app, create an account, and complete a women-focused health questionnaire covering your medical history and weight loss goals.

Provider Review

A licensed provider reviews your health profile and, if approved, prescribes compounded semaglutide. Most reviews are completed within 24 hours.

Monthly Auto-Delivery

Compounded semaglutide ships free to your door monthly. Manage prescriptions, message providers, and access women's health resources through the Hers app.

Medications Available

Wegovy (brand-name injection pen)Wegovy (brand-name oral pill)Zepbound (brand-name via Lilly/Hims-Hers partnership)Semaglutide (compounded injectable)Semaglutide (compounded oral pill)Tirzepatide (compounded)

Pricing Details

Brand Wegovy Pen or Pill

$149/mo

FDA-approved Wegovy pen or oral pill via the 2026 Novo Nordisk partnership — one of the lowest brand-name cash prices available

Compounded Semaglutide Injection

$199/mo

All-inclusive compounded semaglutide with consultations and free shipping

Compounded Tirzepatide

$199/mo

Compounded tirzepatide injectable (added 2026); higher doses reach $299/mo

Zepbound (Brand via Lilly partnership)

$1899/mo

FDA-approved Zepbound access via the Lilly/Hims-Hers partnership — brand cash price

Cancellation policy: Cancel anytime online or through the app

Ready to get started?

Visit Hers

7.3

Our Verdict

The 2026 Novo Nordisk partnership makes Hers materially different from where it was a year ago — FDA-approved Wegovy pen and pill from $149/mo is one of the cheapest brand-name GLP-1 routes available. Compounded semaglutide stays at $199/mo, and compounded tirzepatide and Zepbound are now on the menu. Best for women who want brand-name access at competitive pricing inside a female-focused platform.

Key differentiator: The only major women-focused telehealth platform with both a direct Novo Nordisk partnership (Wegovy pen + pill from $149/mo) and a Lilly partnership (Zepbound access) alongside compounded semaglutide and tirzepatide.

Frequently Asked Questions

How much is Wegovy through Hers?+

FDA-approved brand Wegovy pen and Wegovy oral pill start at $149/mo through the 2026 Novo Nordisk partnership — this is one of the lowest brand-name GLP-1 cash prices available from any telehealth platform. Pricing varies by dose.

Does Hers offer tirzepatide or Zepbound?+

Yes. Hers added compounded tirzepatide in 2026 starting at $199/mo. FDA-approved Zepbound is also available via the Lilly/Hims-Hers partnership, priced at ~$1,899/mo cash — read as access, not value.

Is Hers the same as Hims for GLP-1?+

Same parent company (Hims & Hers Health, NYSE: HIMS), same Novo Nordisk partnership structure, and same compounded pricing. Hers is branded specifically for women with women-focused health content and additional services (hormonal health, skin care, mental wellness).